Literature DB >> 9508296

Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

F Gamboa1, G Fernandez, E Padilla, J M Manterola, J Lonca, P J Cardona, L Matas, V Ausina.   

Abstract

We evaluated the initial version of the Amplified Mycobacterium Tuberculosis Direct Test (Gen-Probe) (AMTDT 1) and the new version of AMTDT (AMTDT 2) for the detection of Mycobacterium tuberculosis directly from respiratory and nonrespiratory samples and compared the results with those of culture and staining methods. The assays were applied to 410 respiratory and 272 nonrespiratory samples collected from 515 patients. The combination of the culture results and clinical diagnosis was considered to be the "gold standard." Ninety-five respiratory specimens were collected from 67 patients with a diagnosis of pulmonary tuberculosis (TB) and 68 nonrespiratory specimens were collected from 61 patients with a diagnosis of extrapulmonary TB. With respiratory specimens, the sensitivity, specificity, and positive and negative predictive values were 83, 100, 100, and 96%, respectively, for AMTDT 1 and 94.7, 100, 100, and 98.4%, respectively, for AMTDT 2. With nonrespiratory specimens, the sensitivity, specificity, and positive and negative predictive values were 83, 100, 100, and 94%, respectively, for AMTDT 1 and 86.8, 100, 100, and 98.4%, respectively, for AMTDT 2. The overall results of AMTDT 1 and AMTDT 2 were concordant for 97% (661 of 682) of the samples. Statistically significant differences in sensitivities were found between AMTDT 1 and AMTDT 2 with respiratory specimens. It was concluded that although both nucleic acid amplification methods are rapid, sensitive, and specific for the detection of M. tuberculosis complex in all types of clinical samples, AMTDT 2 appeared to be more sensitive than AMTDT 1 when applied to smear-negative specimens. In contrast AMTDT 2 is more susceptible than AMTDT 1 to inhibitory substances in the amplification reaction. The turnaround time of AMTDT 2 is shorter (3.5 h) than that for AMTDT 1 (5 h).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508296      PMCID: PMC104609          DOI: 10.1128/JCM.36.3.684-689.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  [Media and methods of culture suitable for the reanimation and multiplication in vitro of Mycobacterium tuberculosis of reduced vitality, of ephemeral viability, or in a state of quiescence].

Authors:  P J COLETSOS
Journal:  Ann Inst Pasteur (Paris)       Date:  1960-10

2.  Comparison of MB-Check, BACTEC, and egg-based media for recovery of mycobacteria.

Authors:  C Abe; S Hosojima; Y Fukasawa; Y Kazumi; M Takahashi; K Hirano; T Mori
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture.

Authors:  M Goto; S Oka; K Okuzumi; S Kimura; K Shimada
Journal:  J Clin Microbiol       Date:  1991-11       Impact factor: 5.948

4.  Rapid diagnosis of tuberculosis by amplification of mycobacterial DNA in clinical samples.

Authors:  A Brisson-Noël; B Gicquel; D Lecossier; V Lévy-Frébault; X Nassif; A J Hance
Journal:  Lancet       Date:  1989-11-04       Impact factor: 79.321

5.  Polymerase chain reaction for detection of Mycobacterium tuberculosis.

Authors:  U Sjöbring; M Mecklenburg; A B Andersen; H Miörner
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

6.  Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification.

Authors:  D De Wit; L Steyn; S Shoemaker; M Sogin
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

7.  Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation.

Authors:  A Brisson-Noel; C Aznar; C Chureau; S Nguyen; C Pierre; M Bartoli; R Bonete; G Pialoux; B Gicquel; G Garrigue
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

8.  Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.

Authors:  P Del Portillo; L A Murillo; M E Patarroyo
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Detection of Mycobacterium tuberculosis DNA in clinical samples by using a simple lysis method and polymerase chain reaction.

Authors:  L Folgueira; R Delgado; E Palenque; A R Noriega
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  Evaluation of practical chromatographic procedures for identification of clinical isolates of mycobacteria.

Authors:  M Luquin; V Ausina; F López Calahorra; F Belda; M García Barceló; C Celma; G Prats
Journal:  J Clin Microbiol       Date:  1991-01       Impact factor: 5.948

View more
  35 in total

1.  Inhibitory effect of Alpha-Tec XPR-plus phosphate buffer on the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct test.

Authors:  P Della-Latta; V Jonas
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

2.  Evaluation of the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis in pulmonary and extrapulmonary samples: a multicenter study.

Authors:  Gianna Mazzarelli; Laura Rindi; Paola Piccoli; Claudio Scarparo; Carlo Garzelli; Enrico Tortoli
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

4.  Clinical evaluation of the BDProbeTec ET system for rapid detection of Mycobacterium tuberculosis.

Authors:  J S Bergmann; W E Keating; G L Woods
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

5.  Assessment of laboratory performance of nucleic acid amplification tests for detection of Mycobacterium tuberculosis.

Authors:  John C Ridderhof; Laurina O Williams; Sue Legois; Peter A Shult; Beverly Metchock; Louise N Kubista; James H Handsfield; Ronald J Fehd; Pamela H Robinson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

Review 6.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

7.  Comparison of the real-time PCR method and the Gen-Probe amplified Mycobacterium tuberculosis direct test for detection of Mycobacterium tuberculosis in pulmonary and nonpulmonary specimens.

Authors:  Nadine Lemaître; Sylvie Armand; Anne Vachée; Odile Capilliez; Christine Dumoulin; René J Courcol
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 8.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

Review 9.  Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis.

Authors:  S Greco; E Girardi; A Navarra; C Saltini
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

10.  Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria.

Authors:  B A Hanna; A Ebrahimzadeh; L B Elliott; M A Morgan; S M Novak; S Rusch-Gerdes; M Acio; D F Dunbar; T M Holmes; C H Rexer; C Savthyakumar; A M Vannier
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.